InsiderClue
Stocks · Health care · Surgical & Medical Instruments & Apparatus

PULSE BIOSCIENCES, INC.

PLSE Clue Score37
United States Fiscal year ends December CIK 0001625101 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

20
Insider
Date
Role
Action
Shares
Price
Amount
Kevin Patrick Danahy
18 Feb 2026
Chief Commercial Officer
Sold after exercise
5,000
$23.64
$118.20K
Kevin Patrick Danahy
17 Feb 2026
Chief Commercial Officer
Sold after exercise
20,000
$23.63
$472.60K
Kevin Patrick Danahy
13 Feb 2026
Chief Commercial Officer
Sold after exercise
20,000
$23.53
$470.60K
Kevin Patrick Danahy
12 Feb 2026
Chief Commercial Officer
Sold after exercise
20,000
$23.37
$467.40K
Kevin Patrick Danahy
11 Feb 2026
Chief Commercial Officer
Sold after exercise
20,000
$25.20
$504.00K
Kevin Patrick Danahy
10 Feb 2026
Chief Commercial Officer
Sold after exercise
20,000
$23.52
$470.40K
Kevin Patrick Danahy
9 Feb 2026
Chief Commercial Officer
Sold after exercise
20,000
$21.45
$429.00K
Kevin Patrick Danahy
2 Oct 2025
Chief Commercial Officer
Sold after exercise
4,600
$18.53
$85.24K
Kevin Patrick Danahy
19 Sep 2025
Chief Commercial Officer
Sold after exercise
400
$18.48
$7.39K
Kevin Patrick Danahy
18 Sep 2025
Chief Commercial Officer
Sold after exercise
20,000
$18.49
$369.80K
Darrin Uecker
17 Sep 2025
Chief Technology Officer
Sold after exercise
20,000
$16.21
$324.20K
Darrin Uecker
16 Sep 2025
Chief Technology Officer
Sold after exercise
25,000
$16.28
$407.00K
Darrin Uecker
15 Sep 2025
Chief Technology Officer
Sold after exercise
25,000
$15.77
$394.25K
Darrin Uecker
12 Sep 2025
Chief Technology Officer
Sold after exercise
25,000
$14.32
$358.00K
Darrin Uecker
11 Sep 2025
Chief Technology Officer
Sold after exercise
25,000
$14.78
$369.50K
Thierry B. Thaure
12 May 2017
Director
Sold after exercise
5,000
$24.90
$124.50K
Thierry B. Thaure
12 May 2017
Director
Sold after exercise
5,000
$23.90
$119.50K
Robert J. Greenberg
10 May 2017
Director
Sold after exercise
2,820
$21.87
$61.66K
Robert J. Greenberg
10 May 2017
Director
Sold after exercise
22,180
$21.03
$466.45K
Thierry B. Thaure
8 May 2017
Director
Sold after exercise
15,000
$22.49
$337.32K
Show all 211 transactions →

What was left out

Form 4 filings counted 196
Amendments (4/A) skipped 5
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 20
Sales at will 3
Transactions with no price 0
Shares from compensation/vesting 29,589,146
History held since 16 Nov 2016